Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback